Tagged with

Indonesia Dr. Agus Prabowo, chairman at LKPP (the Indonesian National Public Procurement Agency) explains the importance of embracing technology to gain efficiency and effectiveness in the public procurement process of healthcare products as well as the outcomes from e-catalogue implementation in Indonesia. Could you please introduce the main activities of LKPP…

Taiwan Dr. Hui-Ting Huang, President of Taiwan Adventist Hospital, discusses the challenges of long-term care and the role preventive medicine plays within this scope, while also providing insights on running one of the most recognized hospitals in Taiwan and establishing a different business model through health promotion. Dr. Huang you were…

Taiwan Dr. Tzu-Ling (Karen) Tseng, CEO of Bio Preventive Medicine Corporation in Taiwan, discusses the innovative technology of its patented biomarkers, the success of DNlite and company’s strategy to grow through partnerships with global pharmaceutical companies. What was your vision when you founded Bio Preventive Medicine Corporation (BPM) in 2014? Can…

Indonesia Dr. Hasbullah Thabrany, chairman at the Center for Social Security Studies Universitas Indonesia (CSSUI) and Senior Health Care Financing Consultant to the National Social Security Council of Indonesia, explains the evolution of the national healthcare insurance system since its creation in 1968 as well as the path of development to…

Greece In terms of value, global giants Pfizer, Novartis and Sanofi lead the way in Greece. Click here to see more facts and figures from Greece

Greece Greece Fact Sheet In comparison to other countries heavily affected by the Eurozone debt crisis, Greece is still struggling to find its feet. Greece fares poorly on almost all macroeconomic indicators compared to the Euro area since the start of the recession. The Greek pharma market has shrunk in value significantly from…

Taiwan C.Y. Cheng, chairman and president of Formosa Laboratories, shares exciting news about the establishment of a new drug development company, Formosa Pharmaceuticals. He explains how the know-how gained from running a successful international API production business will help Formosa avoid the typical mistakes that young R&D companies face. Mr. Cheng,…

Indonesia Dr. Sigit Priohutomo, chairman of DJSN (National Social Security Council of Indonesia), explains DJSN’s action plan to implement the SJSN (Indonesian Social Security System), meant to offer basic social security coverage to the Indonesian population in various areas as well as his future vision of the Indonesian healthcare sector. Could…

Taiwan With 7,000 employees in 25 locations across 12 countries in the region, PAREXEL now has more than a third of its global staff in Asia Pacific (APAC). Albert Liou, Vice Chairman, Asia Pacific, PAREXEL, discusses the biotech momentum that has been boosting the attractiveness of the region in terms of…

Taiwan Chih-Yi Weng, chairlady and CEO of Charsire Biotechnology, one of Taiwan’s leading biotech companies focused on the development of botanical new drugs as well as topical and personal care products, provides insights into the company’s unique business model and its promising and maturing R&D pipeline, while Charsire was ranked in…

Switzerland The southern Swiss canton of Ticino does not have the life science reputation of Basel, Zurich or Geneva, but benefits from an open business environment, strategic location, and a thriving network of pharmaceutical SMEs. “Ticino is really a perfect example of the excellence of Swiss SMEs in the pharma industry, as…

Taiwan Peter Tsai, founder, CEO, and chairman of Orient EuroPharma (OEP), one of the leading groups of healthcare companies in Taiwan, provides insights into his strategic vision to double the group’s revenues within the next five years and nurture the long-term growth of the company he founded in 1982, while OEP’s…